Kewaunee Scientific Corporation

NasdaqGM:KEQU Stock Report

Market Cap: US$126.5m

Kewaunee Scientific Balance Sheet Health

Financial Health criteria checks 5/6

Kewaunee Scientific has a total shareholder equity of $56.2M and total debt of $31.2M, which brings its debt-to-equity ratio to 55.6%. Its total assets and total liabilities are $134.8M and $78.6M respectively. Kewaunee Scientific's EBIT is $14.1M making its interest coverage ratio 7.8. It has cash and short-term investments of $23.3M.

Key information

55.6%

Debt to equity ratio

US$31.23m

Debt

Interest coverage ratio7.8x
CashUS$23.27m
EquityUS$56.21m
Total liabilitiesUS$78.56m
Total assetsUS$134.77m

Recent financial health updates

Recent updates

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23
Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11
Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19
Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

Financial Position Analysis

Short Term Liabilities: KEQU's short term assets ($96.8M) exceed its short term liabilities ($40.8M).

Long Term Liabilities: KEQU's short term assets ($96.8M) exceed its long term liabilities ($37.8M).


Debt to Equity History and Analysis

Debt Level: KEQU's net debt to equity ratio (14.2%) is considered satisfactory.

Reducing Debt: KEQU's debt to equity ratio has increased from 22.6% to 55.6% over the past 5 years.

Debt Coverage: KEQU's debt is well covered by operating cash flow (62.6%).

Interest Coverage: KEQU's interest payments on its debt are well covered by EBIT (7.8x coverage).


Balance Sheet


Discover healthy companies